Rating: HOLD
HOLD (5-tier) · quality defensive · conviction: medium
| Metric | Value |
|---|---|
| Current Price | $84 |
| Triangulated Fair Value | $70 (-17% vs spot · triangulated FV) |
| 12-mo Scenario PWEV | $78 (-7% vs spot · 12m PWEV) |
| Forward P/E | 25.9x |
| Market Cap | $363B |
| 52-Week Range | $64–$84 |
EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).
Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-26. Each chart below sits with the part of the thesis it evidences.
General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.
Investment Committee Summary
| Rating | HOLD · HOLD (5-tier) |
| Classification · conviction | quality defensive · medium |
| Triangulated fair value | $70 (-17% vs spot · triangulated FV) |
| 12-mo scenario PWEV | $78 (-7% vs spot · 12m PWEV) |
| Next catalyst | 2026-02-11 — Full-year guidance & long-term algorithm reaffirmation at FY results/CAGNY |
| Primary thesis-break | Organic revenue growth (unit case volume + price/mix) < 0.015 (2 consecutive prints) |
📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.
Rating Bridge
Rating = HOLD because:
- Probability-weighted scenario value implies -7% vs spot
- Monte Carlo median implies -13% vs spot
- DCF fair value implies -19% vs spot
- Bear case (Structural — GLP-1 Volume Hit / De-Rate) downside is -50% vs spot
- Net: reward/risk of 0.3× is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.
Investment Thesis
At $81.27, roughly 25 times forward earnings, the market prices KO as a durable compounder whose price/mix engine offsets any volume drag and whose defensive premium survives the GLP-1 debate. The engine is less convinced. The probability-weighted target of $81.25 sits on top of spot, so the through-cycle anchors argue the premium is fully paid, not underpaid. The peer cross-check reinforces this: implied prices from median peer EV/revenue ($37) and forward P/E ($53) sit far below spot, and the independent DCF lands near $68, so KO is expensive against both cash flow and comparables. The Base path (5% growth, 34.3% margin, 25x) reproduces the mid-cycle target, but the Monte Carlo splits P/E variance at roughly 79% of total, so the rating is hostage to the multiple, not the operations. That yields HOLD: the franchise quality is real, the entry price is not generous. The single most damaging risk is a structural volume decline that GLP-1 adoption makes durable, collapsing both the earnings base and the defensive multiple at once.
The dashboard below is the whole argument on one page: spot ($84) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The highest-probability bear is the structural GLP-1 path, at 20%. Its mechanism is specific: appetite-suppressant adoption durably lowers per-capita consumption of sugared and even zero-sugar beverages, so volume growth turns negative and price/mix can no longer paper over it. Once volume is falling, the market stops paying a compounder multiple for a staple, and the P/E compresses from the mid-20s toward the mid-teens. Earnings and the multiple derate together, which is why the structural target of $39 sits below the 52-week low of $64. At a net-debt position and a payout that leans on high cash conversion, a simultaneous volume and margin fade would also pressure the buyback that has supported per-share optics.
Key Debate
P/E Multiple explains 79% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q1): management +0.46 vs analyst floor +0.00 → delta +0.46 (n=18 mgmt / 13 Q&A; 65th pctile across the S&P book, z +0.4).
Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q1 | +0.46 | +0.00 | +0.46 |
| 2025Q4 | +0.45 | +0.29 | +0.15 |
| 2025Q3 | +0.47 | +0.25 | +0.21 |
| 2025Q2 | +0.49 | +0.19 | +0.30 |
News (last 365d, 1000 articles): avg ticker sentiment +0.20 (bullish 23% / bearish 2%)
Scenario Analysis
The tree runs from a structural 'Structural — GLP-1 Volume Hit / De-Rate' downside ($42) to a 'Bull — Defensive Re-Rate' bull case ($120); the probability-weighted blend (PWEV $78) is -7% versus spot.
| Scenario | Probability | Target | Return vs spot |
|---|---|---|---|
| Structural — GLP-1 Volume Hit / De-Rate | 20% | $42 | -50% |
| Consumer / Input Recession | 17% | $61 | -27% |
| Base — Pricing + Mix Growth | 35% | $83 | -1% |
| Growth — Emerging Markets + Energy/Zero-Sugar | 20% | $104 | +24% |
| Bull — Defensive Re-Rate | 8% | $120 | +43% |
| Probability-Weighted (PWEV) | — | $78 | -7% |
Scenario rationale — what each probability buys (the driver path behind every target):
- Structural — GLP-1 Volume Hit / De-Rate (20%, $42). Structural impairment — GLP-1 volume hit / de-rate: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 39.0; probability: 0.2.
- Consumer / Input Recession (17%, $61). Cyclical downturn — beverage volume + pricing/mix + emerging-market growth (GLP-1 debate) weakens for 1–2 years before normalising. Drivers — implied_target: 67.45; probability: 0.17.
- Base — Pricing + Mix Growth (35%, $83). Mid-cycle — normalised beverage volume + pricing/mix + emerging-market growth (GLP-1 debate); disciplined capital allocation; steady returns. Drivers — implied_target: 86.25; probability: 0.35.
- Growth — Emerging Markets + Energy/Zero-Sugar (20%, $104). Upside — emerging markets + energy / zero-sugar lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 108.9; probability: 0.2.
- Bull — Defensive Re-Rate (8%, $120). Upside tail — sustained tight conditions or a structural re-rate on emerging markets + energy / zero-sugar. Drivers — implied_target: 125.23; probability: 0.08.
Valuation Triangulation
Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.
| Method | Basis | Fair Value | vs Spot |
|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $73 | -13% |
| Peer P/E re-rate | multiple | $53 | -37% |
| Peer EV/Revenue re-rate | multiple | $37 | -56% |
| Scenario PWEV | multiple | $78 | -7% |
| DCF (5-year + terminal) | cash flow + terminal × | $68 | -19% |
| Triangulated (weighted) | — | $70 | -17% |
Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.
Rating vs blend — the key debate. The rating tracks the multiple-discipline fair value (Monte Carlo $73 + scenario PWEV $78, ≈ spot); the weighted blend $70 (-17%) sits below it because the cash-flow DCF ($68) is materially more conservative than the market multiple. Whether the current multiple is justified is the central question for this name — and the principal downside risk to the rating.
Monte Carlo — the distribution, not a point
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $73 and 34% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (79% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.
DCF — the cash-flow anchor
Independent of the market multiple: a 5-year path, WACC 7.0%, 21x terminal FCF multiple → $68. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median forward multiple (P/E 16.23x) implies $53. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.
Across all anchors the spread is 60% of the median — wide (genuine disagreement — the blend carries low valuation confidence).
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | EBIT | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|---|
| Non-Alcoholic Beverages | $49.3B | 100% | 5% | 34% | $16.9B | 25x | 5% | ESTIMATE |
| EBIT = segment revenue × operating margin (segment EBITDA not shown — per-segment D&A is not separately disclosed). |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | beverage volume + pricing/mix + emerging-market growth (GLP-1 debate) |
| net_debt_or_cash_b | -33.32 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.05 |
| div_yield | 0.0256 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | GLP-1 volume hit / de-rate |
| upside | emerging markets + energy / zero-sugar |
Industry Context — Consumer Staples — Food Bev
This name sits in the Consumer Staples — Food Bev as a beverages. beverage volume + pricing/mix + emerging-market growth (GLP-1 debate) Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.
Value chain: KO (beverages) · PEP (beverages) · MNST (beverages) · MDLZ (packaged_food) · KDP (beverages) · HSY (packaged_food) · KHC (packaged_food) · GIS (packaged_food) · HRL (packaged_food) · MKC (packaged_food) · SJM (packaged_food) · CAG (packaged_food)
| Shared state | Capex path | House view | This name implies |
|---|---|---|---|
| Structural — GLP-1 / Private-Label Volume Hit | 40% | 37% | |
| Mid-Cycle — Price/Mix Offsets Volume | 33% | 35% | |
| Upside — Premiumization / EM Growth | 27% | 28% |
Mapping note: name-level 'Structural — GLP-1 Volume Hit / De-Rate' (20%) + 'Consumer / Input Recession' (17%) map to cluster Structural — GLP-1 / Private-Label Volume Hit (37%); name-level 'Growth — Emerging Markets + Energy/Zero-Sugar' (20%) + 'Bull — Defensive Re-Rate' (8%) map to cluster Upside — Premiumization / EM Growth (28%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.
On the cluster's key downside — Structural — GLP-1 / Private-Label Volume Hit () — this name implies 37% vs the cluster house view of 40% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.
Structure: Shared State — The staples_food_bev cycle is the shared macro driver. Driver — food & beverage volume + price/mix vs private-label + GLP-1 + input costs Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).
Model Appendix
DCF — line items
| Year | Revenue | Op income | − Capex | + D&A | FCF | PV(FCF) |
|---|---|---|---|---|---|---|
| FY+1 | $52B | $18B | $2B | $2B | $14B | $13B |
| FY+2 | $54B | $19B | $2B | $2B | $15B | $13B |
| FY+3 | $57B | $21B | $2B | $2B | $16B | $13B |
| FY+4 | $59B | $22B | $3B | $2B | $17B | $13B |
| FY+5 | $61B | $22B | $3B | $2B | $18B | $12B |
| Terminal | — | — | — | — | $18B × 21x | $262B |
FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 5% of revenue, weighted from the segments) — not a single conversion fudge.
WACC 7.0% · Σ PV(FCF) $65B + PV(terminal) $262B = EV $327B; + net cash → equity $294B ÷ diluted shares 4.32B = $68/share (exit-multiple terminal).
- Gordon (perpetuity-growth) terminal at 2.5% → $73/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
- Incremental ROIC on the forecast capex ≈ 28% vs WACC 7% → above WACC — the build is value-creative.
Peer set
| Peer | EV/Rev | Fwd P/E | Growth | Op margin |
|---|---|---|---|---|
| PEP | 2.437x | 16.23x | 5% | 17% |
| MNST | 10.34x | 41.49x | 5% | 31% |
| KDP | 3.943x | 13.42x | 5% | 19% |
| Median | 3.943x | 16.23x | — | — |
Peer-median fwd P/E → $53; EV/Rev → $37.
Weighted fair-value math
| Anchor | Value | Weight | Contribution |
|---|---|---|---|
| DCF | $68 | 41% | $28 |
| Scenario PWEV | $78 | 29% | $23 |
| Monte Carlo median | $73 | 18% | $13 |
| Peer P/E | $53 | 12% | $6 |
| Triangulated | — | 100% | $70 |
Sensitivity
DCF/share — WACC × terminal multiple
| WACC \ Term× | 14.7x | 17.8x | 21.0x | 24.1x | 27.3x |
|---|---|---|---|---|---|
| 5% | $55 | $65 | $75 | $85 | $95 |
| 6% | $52 | $62 | $71 | $81 | $90 |
| 7% | $50 | $59 | $68 | $77 | $86 |
| 8% | $47 | $56 | $65 | $73 | $82 |
| 9% | $45 | $53 | $62 | $70 | $78 |
DCF/share — revenue CAGR Δ × op-margin Δ
| CAGRΔ \ MgnΔ | -3.0pp | -1.5pp | +0.0pp | +1.5pp | +3.0pp |
|---|---|---|---|---|---|
| -3.0pp | $53 | $56 | $58 | $61 | $64 |
| -1.5pp | $57 | $60 | $63 | $66 | $69 |
| +0.0pp | $62 | $65 | $68 | $71 | $74 |
| +1.5pp | $66 | $70 | $73 | $77 | $80 |
| +3.0pp | $72 | $75 | $79 | $82 | $86 |
Tornado — DCF/share swing by driver (widest first)
| Driver | Low | High | Swing |
|---|---|---|---|
| Revenue CAGR ±3pp | $58 | $79 | $20 |
| Terminal × ±15% | $59 | $77 | $18 |
| Op margin ±3pp | $62 | $74 | $13 |
| WACC ±1pp | $65 | $71 | $7 |
| Capex intensity ±15% | $66 | $70 | $3 |
Company lever — SoP/share vs Non-Alcoholic Beverages multiple (AI re-rating) (base 25x)
| Multiple | 17.5x | 21.2x | 25.0x | 28.7x | 32.5x |
|---|---|---|---|---|---|
| SoP/share | $193 | $235 | $279 | $321 | $365 |
Consensus & Market Expectations
| Reference | Value |
|---|---|
| Street target (mean) | $86 (+2% vs spot · street) |
| House target | $81 (-5.5% vs street) |
| Sell-side coverage | 24 analysts (SB 7 / B 12 / H 4 / S 0 / SS 1; net score 0.5) |
| Consensus FY EPS | $3.48; house below (-6.7%) |
| Consensus FY revenue | $50.0B; house above (+3.3%) |
_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.
Balance Sheet & Liquidity
| Metric | Value |
|---|---|
| Net debt | $31.6B — levered |
| Net debt / EBITDA | 1.89x |
| Interest coverage (EBIT / interest) | 10.7x |
| Current ratio | 1.46x |
| Cash & ST investments | $13.9B |
Balance-sheet data as of 2025-12-31 (Alpha Vantage).
Capital Allocation
| Metric | Value |
|---|---|
| Free cash flow | $5.3B |
| Buybacks / dividends | $0.8B / $8.8B |
| Total shareholder yield | 2.6% |
| Payout as % of FCF | 179.9% |
| Reinvestment (capex / OCF) | 28.5% |
| SBC as % of FCF | 5.3% |
| Allocation stance | returning more than FCF (balance-sheet funded) |
Free-Cash-Flow Quality
| Metric | Value |
|---|---|
| FCF margin | 10.7% |
| FCF conversion (FCF / net income) | 40.4% |
| FCF yield | 1.5% |
| Capex intensity (capex / revenue) | 4.3% |
| FCF − SBC (diagnostic) | $5.0B |
| Capex split (maint / growth) | 70% / 30% — Capital-light concentrate model — most capex sustains production/IT; growth spend funds emerging-market capacity and bottler system investments. Compounder profile skews to maintenance. |
Accounting quality: SBC 0.6% of revenue; cash conversion (OCF/NI) 56% — earnings not cash-backed.
Catalyst Calendar
- 2026-02-11 (~-147d) — Full-year guidance & long-term algorithm reaffirmation at FY results/CAGNY (authored)
- 2026-06-15 (~-23d) — Zero-sugar / energy portfolio innovation and reformulation launches (authored)
- 2026-07-28 (~20d) — Quarterly earnings — est. EPS $0.92 (AV EARNINGS_CALENDAR)
- 2027-01-20 (~196d) — Emerging-market volume trajectory update (India, Africa, LatAm) (authored)
Forecast Track Record
- EPS surprise: beat 100.0% of the last 8 quarters; average surprise +4.0%.
Competitive Moat
Wide moat. KO's moat is genuinely wide — a globally dominant brand portfolio plus a bottler distribution system with unmatched retail penetration supports durable pricing power and a premium terminal multiple; but 'wide' does not mean unlimited: if the GLP-1 volume thesis proves structural and price/mix can no longer offset unit declines, the terminal multiple should compress from a ~25x forward P/E toward the ~18-20x staples-average, and toward ~16x market if volume erosion becomes chronic.
Moat sources:
- Coca-Cola trademark and ~200-brand portfolio (brand equity moat)
- Global bottler/distribution system with near-ubiquitous cold-drink retail placement
- Scale in marketing spend and shelf negotiation vs private label
- Pricing power evidenced by multi-year price/mix ahead of input inflation
Regulatory & Legal Risk
| Issue | Probability | Valuation sensitivity | Horizon |
|---|---|---|---|
| Sugar / soda taxes and front-of-pack labelling mandates spreading across markets | high (~60%) | medium - depresses volume in taxed markets, partially offset by reformulation/mix; ~5% of FV | 12-24m |
| US/EU litigation and scrutiny on artificial sweeteners (aspartame) and 'health' marketing claims | medium (~35%) | low - reputational/marketing constraint, limited direct P&L; ~2% of FV | 12-24m |
Probabilities and sensitivities are analyst estimates, not market-implied.
Scenario Macro & Key Risks
| Scenario | Macro assumption | Key risk |
|---|---|---|
| Structural — GLP-1 Volume Hit / De-Rate | Mass GLP-1 adoption structurally suppresses sugared-beverage consumption in developed markets; investors de-rate staples on secular volume decline. | Price/mix can no longer offset chronic unit declines, breaking the volume-plus-pricing algorithm and compressing the multiple. |
| Consumer / Input Recession | Global consumer downturn with input-cost (sweetener, aluminium, PET, freight) inflation squeezing margins. | Down-trading to private label plus margin compression from unhedged input spikes. |
| Base — Pricing + Mix Growth | Normal global growth; low-single-digit volume, mid-single-digit price/mix delivers the long-term algorithm. | Volume drifts flat-to-negative in developed markets, leaving the algorithm reliant entirely on price (a limit exists). |
| Growth — Emerging Markets + Energy/Zero-Sugar | Strong EM per-capita consumption growth plus successful premiumisation into zero-sugar/energy lifts both volume and mix. | FX translation from EM currencies erodes reported growth; premium-category competition intensifies. |
| Bull — Defensive Re-Rate | Risk-off macro and falling rates drive a flight to defensive quality; investors pay up for KO's durable cash flows. | Re-rate is macro-sentiment-driven and unwinds when risk appetite and rates normalise. |
What the Market Is Pricing In
At the current price, the market pays 24.1× forward EPS, vs the house DCF terminal 21.0×, and a peer median 16.23×. The house DCF sits 19% below spot, so the market is pricing in more than the house case — roughly 2.0pp of revenue CAGR.
Variant perception: the house view is below-consensus, and the thesis is primarily growth-driven.
| Metric | Consensus | House | Importance |
|---|---|---|---|
| Revenue | 50.0 | 51.7 | High |
| EPS | 3.5 | 3.2 | Medium |
| Target price | 86.0 | 81.2 | Medium |
Peer Quality & Weighting
| Peer | Fwd P/E | Growth | Op margin | Quality | Weight cap |
|---|---|---|---|---|---|
| PEP | 16.23× | 5% | 17% | segment | 50% |
| MNST | 41.49× | 5% | 31% | broad | 25% |
| KDP | 13.42× | 5% | 19% | segment | 50% |
Quality-weighted forward P/E: 20.2× (simple median 16.23×). Direct peers count 100%, segment 50%, broad 25%.
Historical-range cross-check: 52-week range $64–$84, centre $73 (-13% vs spot); spot sits at the 103th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.
Risk / Reward & Margin of Safety
| Metric | Value |
|---|---|
| Upside to triangulated FV | $70 (-17% vs spot · triangulated FV) |
| Downside to bear case (Structural — GLP-1 Volume Hit / De-Rate) | $42 (-50% vs spot · bear scenario) |
| Reward/risk ratio | 0.3× |
| Margin of safety (FV vs spot) | -20% |
| P(price > spot) — Monte Carlo | 34% |
Reward/risk compares triangulated upside against the probability-weighted bear target, not the extreme tail. Bull case (Bull — Defensive Re-Rate): $120.
Assumption Register
| Assumption | Value | Used in | Source |
|---|---|---|---|
| WACC | 7.0% | DCF discount rate | estimate (CAPM) |
| Terminal multiple | 21× | DCF exit value | estimate (peer-anchored) |
| Terminal growth | 2.5% | DCF Gordon terminal | estimate |
| SBC dilution | 0.0%/yr | PWEV, MC, DCF (charged once) | estimate (from SBC/rev) |
| EPS basis | consensus forward EPS (broker-adjusted, non-GAAP) | all forward P/E & scenario multiples | definition |
Sensitivity-ranked drivers (widest fair-value swing first): Revenue CAGR ±3pp (20.0); Terminal × ±15% (18.0); Op margin ±3pp (13.0); WACC ±1pp (7.0); Capex intensity ±15% (3.0).
Inputs, Sources & Confidence
Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)
| Input | Value | Type | Source | Confidence | Used in |
|---|---|---|---|---|---|
| Revenue TTM | $49.3B | reported fact | 10-K/10-Q via AV | High | Forecast base, EV/Rev |
| FY+1 guided revenue | $51.7B | company guidance | Company guidance | Medium | Forecast, SoP |
| Consensus FY EPS | $3.4835 | consensus estimate | Sell-side consensus via AV | Medium | Variant perception |
| Diluted shares | 4.324B | reported fact | 10-K via AV | High | Market cap, per-share |
| Net debt / cash | $31.62B | reported fact | Balance sheet via AV | High | EV, DCF equity bridge |
| WACC | 7.0% | house estimate | CAPM (beta/rf) | Medium | DCF discount rate |
| Terminal multiple | 21× | house estimate | Peer/historical range | Medium | DCF exit value |
| Terminal growth | 2.5% | house estimate | Long-run GDP+ | Medium | DCF Gordon terminal |
Source Log
| Source | Type | Date | Used for | Reference |
|---|---|---|---|---|
| Alpha Vantage — GLOBAL_QUOTE / OVERVIEW | market data | 2026-07-08 | Price, market cap, EV, 52-week range, forward P/E | Alpha Vantage 2026-06-26 |
| Company income statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-07-08 | Revenue, gross/operating margin, EBIT, interest expense | INCOME_STATEMENT / latest annual |
| Company balance sheet (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-07-08 | Cash, debt, net debt, leases, equity, coverage | BALANCE_SHEET / latest annual |
| Company cash-flow statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-07-08 | Operating cash flow, capex, FCF, buybacks, dividends, SBC | CASH_FLOW / latest annual |
| Company earnings releases via Alpha Vantage | reported fact | 2026-07-08 | Reported EPS, surprise history | EARNINGS / quarterly |
| Sell-side consensus via Alpha Vantage | consensus estimate | 2026-07-08 | Forward revenue/EPS consensus, analyst count | EARNINGS_ESTIMATES |
| Earnings calendar via Alpha Vantage | market data | 2026-07-08 | Next earnings date, catalyst timing | EARNINGS_CALENDAR |
| Company guidance | company guidance | 2026-07-08 | FY guided revenue / non-GAAP EPS basis | company guidance / earnings call |
| MCH segment model (from filings & disclosures) | house estimate | 2026-07-08 | Segment revenue, margins, multiples, AI decomposition | company_context (authored, tagged) |
| MCH qualitative analysis | inference | 2026-07-08 | Moat, regulatory risk, scenario macro, catalysts | company_context enrichment (authored) |
| MCH investment thesis & falsification triggers | house estimate | 2026-07-08 | Thesis, anti-thesis, thesis-break signals | authored §5.3 |
Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.
Load-Bearing Assumptions
DCF: WACC 7%, terminal multiple 21×, FY+5 revenue $61B. Triangulation leans 41% on DCF, 29% on PWEV.
Reasons the Thesis Could Fail (Falsifiable)
Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:
- Organic revenue growth (unit case volume + price/mix) < 0.015 (2 consecutive prints → Structural — GLP-1 / Private-Label Volume Hit). Base assumes ~5% organic growth. Two prints below 1.5% would signal volume erosion the pricing lever can no longer offset, mapping to the cyclical/structural bear paths.
- Global unit case volume growth < 0.0 (2 consecutive prints → Structural — GLP-1 / Private-Label Volume Hit). The GLP-1 thesis is a volume thesis. Two quarters of outright volume decline would corroborate structural demand impairment rather than price-led optics.
- Comparable (non-GAAP) operating margin < 0.315 (2 consecutive prints → Consumer / Input Recession). Base carries a 34.3% segment operating margin. Sustained margin below ~31.5% would confirm input, FX or reinvestment pressure consistent with the recession path (33.0%) trending toward structural (30.0%).
- Capital expenditure > 3.0 (single event → Consumer / Input Recession). History runs at $2.11B. A step to above $3.0B without a commensurate volume response would break the asset-light, high-ROIC premise the multiple relies on.
- Free cash flow conversion (FCF / net income) < 0.8 (2 consecutive prints → Consumer / Input Recession). The dividend and buyback rely on high cash conversion. Two prints below 0.80 would flag working-capital or reinvestment strain undermining the defensive-quality case.
Fact / Inference / Speculation
- FACT: Spot $84; 52-week range $64–$84; engine rating HOLD; base-case target $81 (-3%). (source: Alpha Vantage 2026-06-26, 8 July 2026)
- INFERENCE: Triangulated FV $70 (-17% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
- SPECULATION: At current prices the embedded bet is that the market keeps paying the current multiple through the capex cycle — a regime call the engine cannot verify from fundamentals alone.
Recommendation: HOLD
Balanced: triangulated fair value $70 (-17% vs spot); the outcome hinges on P/E Multiple. The debate is P/E Multiple — fundamentally a multiple/regime call.
Disclosures & Limitations
This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.
- No suitability assessment has been performed for any individual.
- Market data may be delayed or inaccurate; figures are as of the analysis date.
- Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
- Forecasts are uncertain; past performance is not indicative of future returns.
- The author or publisher may hold positions in securities mentioned.
- Users should verify information against primary sources (company filings) before acting.
- Investing involves risk of loss; there is no guarantee any target price is achieved.
- Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.